Roche Holding AG (TSX:ROG)
Canada · Delayed Price · Currency is CAD 28.31
+0.11 (0.39%)
At close: Feb 6, 2026
Revenue
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Roche Pharmaceuticals Revenue | 44.59B | 43.30B | 40.52B | |||||||||||
Roche Pharmaceuticals Revenue Growth | 2.98% | 6.85% | -0.20% | |||||||||||
Chugai Revenue | 2.93B | 2.87B | 3.75B | |||||||||||
Chugai Revenue Growth | 2.05% | -23.26% | -24.33% | |||||||||||
Pharmaceuticals Revenue | 47.52B | 46.17B | 44.27B | |||||||||||
Pharmaceuticals Revenue Growth | 2.92% | 4.31% | -2.82% | |||||||||||
Diagnostics Revenue | 14.07B | 14.32B | 14.45B | |||||||||||
Diagnostics Revenue Growth | -1.76% | -0.88% | -18.49% |
Revenue by Geography
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Switzerland Revenue | 747.00M | 679.00M | |||||||||||
Switzerland Revenue Growth | 10.02% | -0.59% | |||||||||||
Germany Revenue | 2.93B | 2.87B | |||||||||||
Germany Revenue Growth | 2.13% | -12.99% | |||||||||||
Rest of Europe Revenue | 10.29B | 9.70B | |||||||||||
Rest of Europe Revenue Growth | 6.06% | -6.03% | |||||||||||
Europe Revenue | 13.97B | 13.25B | |||||||||||
Europe Revenue Growth | 5.41% | -7.38% | |||||||||||
United States Revenue | 28.90B | 27.18B | |||||||||||
United States Revenue Growth | 6.32% | -2.71% | |||||||||||
Rest of North America Revenue | 889.00M | 837.00M | |||||||||||
Rest of North America Revenue Growth | 6.21% | -23.98% | |||||||||||
North America Revenue | 29.79B | 28.02B | |||||||||||
North America Revenue Growth | 6.32% | -3.51% | |||||||||||
Latin America Revenue | 3.25B | 2.97B | |||||||||||
Latin America Revenue Growth | 9.36% | 3.52% | |||||||||||
Japan Revenue | 3.15B | 4.37B | |||||||||||
Japan Revenue Growth | -27.89% | -23.20% | |||||||||||
Rest of Asia Revenue | 9.09B | 8.89B | |||||||||||
Rest of Asia Revenue Growth | 2.19% | -9.77% | |||||||||||
Asia Revenue | 12.24B | 13.26B | |||||||||||
Asia Revenue Growth | -7.73% | -14.69% | |||||||||||
Africa, Australia and Oceania Revenue | 1.25B | 1.21B | |||||||||||
Africa, Australia and Oceania Revenue Growth | 3.14% | -20.26% |
EBIT
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Roche Pharmaceuticals Operating Profit | 14.13B | 12.34B | 14.65B | |||||||||||
Roche Pharmaceuticals Operating Profit Growth | 14.55% | -15.77% | 10.33% | |||||||||||
Chugai Operating Profit | 3.16B | 3.21B | 2.92B | |||||||||||
Chugai Operating Profit Growth | -1.56% | 10.19% | -26.91% | |||||||||||
Pharmaceuticals Operating Profit | 17.63B | 15.59B | 17.91B | |||||||||||
Pharmaceuticals Operating Profit Growth | 13.08% | -12.97% | 6.83% | |||||||||||
Diagnostics Operating Profit | 1.24B | 1.95B | 1.39B | |||||||||||
Diagnostics Operating Profit Growth | -36.38% | 39.80% | -66.45% | |||||||||||
Corporate Operating Profit | -4.19B | -4.12B | -3.91B |
Capital Expenditures
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Roche Pharmaceuticals Capital Expenditures | 4.98B | 6.00B | 8.68B | |||||||||||
Roche Pharmaceuticals Capital Expenditures Growth | -17.11% | -30.87% | 242.16% | |||||||||||
Chugai Capital Expenditures | 476.00M | 350.00M | 490.00M | |||||||||||
Chugai Capital Expenditures Growth | 36.00% | -28.57% | -7.90% | |||||||||||
Pharmaceuticals Capital Expenditures | 5.45B | 6.35B | 9.17B | |||||||||||
Pharmaceuticals Capital Expenditures Growth | -14.18% | -30.75% | 198.83% | |||||||||||
Diagnostics Capital Expenditures | 2.45B | 2.44B | 2.64B | |||||||||||
Diagnostics Capital Expenditures Growth | 0.45% | -7.83% | 45.73% | |||||||||||
Corporate Capital Expenditures | 66.00M | 78.00M | 88.00M | |||||||||||
Corporate Capital Expenditures Growth | -15.38% | -11.36% | -4.35% |
Updated Jun 30, 2025. Data Source: Fiscal.ai.